Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Zevra Therapeutics, Inc. is a commercial-stage rare disease company with a late-stage pipeline committed to bringing therapeutics to people living with rare diseases. Its commercial products and active development assets are MIPLYFFA, Arimoclomol, OLPRUVA, and Celiprolol. Its lead product, Niemann-Pick disease type C (NPC), is a rare, progressive neurodegenerative disorder. NPC is an ultra-rare and progressive neurodegenerative disease characterized by an inability of the body to transport cholesterol and lipids inside of cells. OLPRUVA (sodium phenylbutyrate) for oral suspension is approved in the United States as adjunctive therapy to standard of care, which includes dietary management, for the chronic management of UCDs involving deficiencies of carbamylphosphate synthetase, ornithine transcarbamylase, or argininosuccinic acid synthetase. Celiprolol is a selective adrenoceptor modulator (SAM). Celiprolol is approved in certain EU states for the treatment of hypertension and angina.
Find out what a historical investment in Zevra Therapeutics Inc would be worth today using our ZVRA stock calculator.
Buying ZVRA shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Zevra Therapeutics Inc in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in ZVRA
What is the ticker symbol of Zevra Therapeutics Inc?
The ticker symbol for Zevra Therapeutics Inc is ZVRA.
How much is one share of ZVRA?
One share of ZVRA is valued at $9.07 as of 20 November 2026.
What is the market capitalisation of Zevra Therapeutics Inc ZVRA?
As of 20 November 2026 Zevra Therapeutics Inc has a market cap of $552.20M.
What is the P/E ratio of ZVRA?
The Price to Earnings ratio of ZVRA is 7.09.
What is the Earnings Per Share of ZVRA?
The Earnings Per Share of ZVRA is $1.28.
What is the 52-week high for Zevra Therapeutics Inc stock?
The Zevra Therapeutics Inc 52-week high stock price is $15.04.
What is the 52-week low for Zevra Therapeutics Inc stock?
The Zevra Therapeutics Inc 52-week low stock price is $8.01.
Can I buy ZVRA shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy ZVRA shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in ZVRA on Stake
Buy ZVRA from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of ZVRA from only US$10 with fractional shares